Reaction

Renal Cyst Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 158 reports · 3 co-occurring drugs

As of the last recalculation, Renal Cyst Infection appears in 158 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is TOLVAPTAN (PRR 161.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Tolvaptan16161.3161.4
Crizotinib11122.4122.6
Methoxy Polyethylene Glycol-Epoetin Beta336.536.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.